Cymbalta

formulated to manage major depressive disorder to support mental wellness.

Strengths: 20 · 30 · 40 · 60mg

Medicine details

Alternative names

Yentreve

Therapeutic class

Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)

Pharmacological class

SNRI

Contraindications

uncontrolled narrow-angle glaucoma; concurrent use of MAO inhibitors

Precautions and warnings

monitor for suicidal ideation; may impair alertness

Minor side effects

nausea; dry mouth

Moderate side effects

insomnia; dizziness; somnolence

Dosage forms

Prolonged-release capsule, hard

Administration route

Oral use

Patient summary

formulated to manage major depressive disorder to support mental wellness.

Prescription status

POM

Manufacturer

Eli Lilly

Onset Time

1–2 weeks

Duration

24 hours

Storage instructions

Store below 25°C in a dry place.

Drug interactions

alcohol; st. john's wort

Pregnancy and breastfeeding

Pregnancy: consult specialist. Breastfeeding: discuss with physician.

Serious side effects

serotonin syndrome — requires immediate medical attention; hepatitis — requires immediate medical attention

Mechanism of action

it inhibits the neuronal uptake of serotonin and norepinephrine, resulting in increased levels of these neurotransmitters in the synaptic cleft.

Cymbalta

formulated to manage major depressive disorder to support mental wellness.

Editorial Notes

  • Active ingredient(s): Duloxetine
  • Listed indication(s): Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathic Pain

Usually available as

  • 120 tablets - 20 mg13-20-mg-2627
  • 60 tablets - 30 mg13-30-mg-2631
  • 60 tablets - 40 mg13-40-mg-2637